These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26 related articles for article (PubMed ID: 12915932)
1. Lack of association between baseline plasma homocysteine concentrations and restenosis rates after a first elective percutaneous coronary intervention without stenting. Wong CK; Hammett CJ; The R; French JK; Gao W; Webber BJ; Elliott JM; Hamer AW; Ormiston JA; Webster MW; Stewart RA; Ameratunga RV; White HD Heart; 2004 Nov; 90(11):1299-302. PubMed ID: 15486126 [TBL] [Abstract][Full Text] [Related]
3. Provisional stenting for multivessel PCI. Han B; Liu L; Aboud M; Nahir M; Hasin Y Int J Cardiovasc Intervent; 2005; 7(1):46-51. PubMed ID: 16019615 [TBL] [Abstract][Full Text] [Related]
4. Clinical outcome of patients undergoing low aggressive angioplasty combined with brachytherapy and short-term dual antiplatelet therapy for in-stent restenosis. Di Pede F; Buja P; Millosevich P; Grassi G; Celestre M; Zuin G; Marchetti C; Pizzi G; Antonello M; Bindoni L; Raviele A J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):731-6. PubMed ID: 17001233 [TBL] [Abstract][Full Text] [Related]
5. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial. Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Van den Branden F; Van Langenhove G; J Am Coll Cardiol; 2007 Jul; 50(3):261-7. PubMed ID: 17631219 [TBL] [Abstract][Full Text] [Related]
6. Impact of interventionalist volume, experience, and board certification on coronary angioplasty outcomes in the era of stenting. Harjai KJ; Berman AD; Grines CL; Kahn J; Marsalese D; Mehta RH; Schreiber T; Boura JA; O'Neill WW Am J Cardiol; 2004 Aug; 94(4):421-6. PubMed ID: 15325922 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: the randomized, double-blind, placebo-controlled, multicenter Verapamil Slow-Release for Prevention of Cardiovascular Events After Angioplasty (VESPA) Trial. Bestehorn HP; Neumann FJ; Büttner HJ; Betz P; Stürzenhofecker P; von Hodenberg E; Verdun A; Levai L; Monassier JP; Roskamm H J Am Coll Cardiol; 2004 Jun; 43(12):2160-5. PubMed ID: 15193674 [TBL] [Abstract][Full Text] [Related]
8. Operator experience and long term outcome after percutaneous coronary intervention. Mueller C; Hodgson JM; Brutsche M; Bestehorn HP; Marsch S; Perruchoud AP; Roskamm H; Buettner HJ Can J Cardiol; 2003 Aug; 19(9):1047-51. PubMed ID: 12915932 [TBL] [Abstract][Full Text] [Related]
10. Percutaneous coronary intervention for stable coronary artery disease. Katritsis DG; Meier B J Am Coll Cardiol; 2008 Sep; 52(11):889-93. PubMed ID: 18772057 [TBL] [Abstract][Full Text] [Related]
11. Operator Experience and Outcomes After Left Main Percutaneous Coronary Intervention. Kanmanthareddy A; Anugula D; Kar B Curr Cardiol Rep; 2018 Mar; 20(5):29. PubMed ID: 29572751 [TBL] [Abstract][Full Text] [Related]
12. The relationship between hospital or operator volume and outcomes of coronary patients undergoing percutaneous coronary interventions. Dibra A; Kastrati A; Schühlen H; Schömig A Z Kardiol; 2005 Apr; 94(4):231-8. PubMed ID: 15803259 [TBL] [Abstract][Full Text] [Related]